NCT07692321

Brief Summary

The overall objective: to co-design and implement targeted and timely community led strategies to improve the health of the Next Generation and end the intergenerational impact of T2D in this population.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
56mo left

Started Aug 2026

Longer than P75 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 9, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 31, 2026

Expected
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2030

9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2031

Last Updated

July 9, 2026

Status Verified

July 1, 2026

Enrollment Period

3.8 years

First QC Date

July 2, 2026

Last Update Submit

July 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Obesity

    Development of obesity defined by the International task force on obesity cut offs for age and gender.

    18 years

  • Type 2 Diabetes

    Development of type 2 diabetes defined by diagnostic criteria in the Canadian Diabetes association 2008 guidelines in childhood (≤ 7 years) or adolescence (12-16 years).

    18 years

Study Arms (3)

Co-develop and implement a community-based perinatal education and support program using navigators

ACTIVE COMPARATOR

The implementation of a community-based navigator to facilitate multiple points of pre and post-partum contact as well as individualized connection to preexisting and co-developed urban and northern pre- and post-natal supports, will increase rates of initiation and duration (≥6 month) of breastfeeding in the NextGen mothers from 58% to ≥75%.

Behavioral: Breastfeeding and perinatal education and support

Extend the scope of the NextGen Cohort

ACTIVE COMPARATOR

Community based point of care HbA1c testing will improve access to annual screening for pre-diabetes and diabetes in the Next Gen Cohort. CGM can detect early dysglycemia (below the threshold for the diagnosis of prediabetes) in young children at high risk for childhood-onset T2D. In addition, we hypothesize that CGM use will be well tolerated and feasible in young children.

Device: Purchasing HbA1c machines for communitiesDevice: Continuous Glucose Monitoring

Co-develop and implement community led land-based programming for parent(s) and preschool children

ACTIVE COMPARATOR

Land-based community programming for caregivers and children aged 4-5 years is feasible and will encourage healthy nutrition choices and physical activity. Ultimately, we hypothesize that this will improve the health and well-being of this high-risk population and improve cardiometabolic health.

Behavioral: Land-based Wellness Programming

Interventions

Co-develop and implement a community-based perinatal education and support program using navigators to support breast feeding, maternal nutrition and activity, and early infancy/childhood nutrition and activity.

Co-develop and implement a community-based perinatal education and support program using navigators

This will allow study participants to conduct earlier and more frequent screening for early dysglycemia, prediabetes and T2D.

Extend the scope of the NextGen Cohort

We will investigate the use of continuous glucose monitoring (CGM) to detect early dysglycemia in the Next Gen cohort.

Extend the scope of the NextGen Cohort

Co-develop and implement community led land-based programming for parent(s) and preschool children aged 4-5 years to encourage traditional nutrition and activities to maintain wellness.

Co-develop and implement community led land-based programming for parent(s) and preschool children

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women with type 2 diabetes, gestational diabetes, or no diabetes.
  • From self-identified Indigenous heritage (e.g., Cree, Oji-Cree, Métis, Anishinaabe, etc.).
  • Are delivering and residing in Manitoba.
  • Mother/Father and children must be biological family members.

You may not qualify if:

  • Mothers or children with type 1 diabetes.
  • Residing outside of Manitoba.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Research Institute of Manitoba/University of Manitoba

Winnipeg, Manitoba, R3E 3P4, Canada

Location

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes, Gestational

Interventions

LactationPalliative CareContinuous Glucose Monitoring

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological PhenomenaPostpartum PeriodPatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicInvestigative Techniques

Study Officials

  • Brandy A Wicklow, MD, MSc

    University of Manitoba, Children's Hospital Research Institute of Manitoba

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brandy A Wicklow, MD, MSc

CONTACT

Elizabeth AC Sellers, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2026

First Posted

July 9, 2026

Study Start (Estimated)

August 31, 2026

Primary Completion (Estimated)

June 30, 2030

Study Completion (Estimated)

March 31, 2031

Last Updated

July 9, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

In cooperation with OCAP principles.

Locations